세계의 유전형 분석 시장 보고서(2025년)
Genotyping Global Market Report 2025
상품코드 : 1824383
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

유전형 분석 시장 규모는 앞으로 수년간 급성장할 것으로 예측됩니다. 2029년에는 CAGR 17.8%로 512억 2,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 임상진단에서의 채택 증가, 맞춤형 의료에 대한 수요 증가, 연구개발 이니셔티브의 상승, 농업과 가축에서의 용도의 확대에 기인한다고 생각됩니다. 예측기간의 주요 동향으로는 약리 유전체학 수요 증가, 차세대 시퀀싱(NGS)의 진보, 정밀의료 이니셔티브의 확대, 소비자 직접(DTC) 유전자 검사의 성장, 암 유전체학와 맞춤형 치료에 대한 주력 등이 있습니다.

향후 5년간의 성장률 17.8%라고 하는 예측은 전회의 예측으로부터 0.1%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 상승은 프랑스나 캐나다에서 조달하는 단일염기다형성 배열(SNP arrays) 및 PCR 기반 유전형 분석 키트의 비용이 상승하면서, 약리 유전체 검사의 지연을 악화시켜, 맞춤형 의료의 실시 비용을 상승시킴으로써, 미국의 클리닉에 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.

암과 유전성 질환의 이환율 상승은 앞으로 수년간의 유전형 분석 시장의 성장을 가속할 것으로 예측됩니다. 암은 신체의 거의 모든 장기와 조직에서 발병 할 수있는 광범위한 질병을 포함하지만, 유전자 질환은 전형적인 DNA 서열의 편차에서 발생합니다. 유전형 분석을 통해 과학자는 단일 염기 돌연변이, 사본 수 돌연변이, DNA의 중요한 구조 변화를 포함한 유전적 돌연변이를 조사할 수 있습니다. 이 유전자 검사는 특정 암의 발병 위험을 높일 수 있는 특정 유전자 돌연변이를 확인하려고 합니다. 예를 들어 2024년 2월 스위스에 본부를 두는 국제적인 공중위생에 중점을 둔 기관인 세계보건기구(WHO)는 2022년에는 약 2,000만명의 암 환자가 새롭게 발생하여 970만명이 사망했다고 보고했습니다. 게다가 암으로 진단받은 지 5년 후에 생존했던 사람의 수는 5,350만 명이었습니다. 또한 2023년 2월, 영국에 등록된 자선단체인 Gene People UK는 어린이 25명 중 1명이 유전 질환을 가지고 있다고 추정했습니다. 영국에서는 매년 약 3만 건 이상의 유전 질환이 아기와 어린이에게 새롭게 진단된다는 의미이며, 현재 240만 명 이상의 아동과 성인이 유전 질환을 가지고 살아가고 있는 것으로 보고됐습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

Genotyping is a laboratory procedure that involves examining an individual's germline DNA to identify specific variations in nucleotides or bases. Researchers utilize genotyping to explore genetic variants, including single nucleotide variations, copy number variations, and substantial structural alterations in DNA. This technique finds applications in diverse fields such as agriculture, medicine, and basic science.

The primary categories of genotyping products and services encompass instruments, reagents and kits, bioinformatics, and genotyping services. An instrument is a tool designed to measure various parameters, such as speed, height, or sound. In the context of genotyping, instruments are employed to investigate genetic variations such as significant structural alterations in DNA, copy number variations, and single nucleotide variations. Various technologies are incorporated, including microarrays, capillary electrophoresis, sequencing, polymerase chain reaction, matrix-assisted laser desorption or ionization (Maldi-TOF) mass spectrometry, and other technologies. These technologies serve multiple applications, including pharmacogenomics, diagnostics, personalized medicine, animal genetics, agricultural biotechnology, among others. The end-users of genotyping products and services include pharmaceutical and biopharmaceutical companies, diagnostics and research laboratories, academic institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The genotyping market research report is one of a series of new reports from The Business Research Company that provides genotyping market statistics, including genotyping industry global market size, regional shares, competitors with a genotyping market share, detailed genotyping market segments, market trends and opportunities, and any further data you may need to thrive in the genotyping industry. This genotyping market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genotyping market size has grown rapidly in recent years. It will grow from $23.04 billion in 2024 to $26.55 billion in 2025 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to government initiatives and funding, rapid decline in genotyping costs, expansion of biobanks and genetic databases, increasing prevalence of genetic disorders, pharmacogenomics and drug development.

The genotyping market size is expected to see rapid growth in the next few years. It will grow to $51.22 billion in 2029 at a compound annual growth rate (CAGR) of 17.8%. The growth in the forecast period can be attributed to increased adoption in clinical diagnostics, growing demand for personalized medicine, rise in research and development initiatives, expanding application in agriculture and livestock. Major trends in the forecast period include rise in demand for pharmacogenomics, advancements in next-generation sequencing (ngs), expansion in precision medicine initiatives, growth in direct-to-consumer (dtc) genetic testing, focus on cancer genomics and personalized therapies.

The forecast of 17.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. clinics by driving up the cost of single nucleotide polymorphism arrays SNP arrays and PCR-based genotyping kits sourced from France and Canada, exacerbating delays in pharmacogenomic testing and elevating personalized medicine implementation costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of cancer and genetic disorders is anticipated to drive growth in the genotyping market in the coming years. Cancer encompasses a wide range of diseases that can initiate in nearly any organ or tissue within the body, while genetic disorders arise from deviations in the typical DNA sequence. Genotyping enables scientists to examine genetic variations, including single nucleotide variations, copy number variations, and significant structural changes in DNA. This form of genetic testing seeks to identify specific gene mutations that may increase an individual's risk of developing certain cancers. For example, in February 2024, the World Health Organization, a Switzerland-based agency focused on international public health, reported that in 2022, there were approximately 20 million new cancer cases, leading to 9.7 million deaths. Additionally, an estimated 53.5 million individuals were alive five years post-cancer diagnosis. Furthermore, in February 2023, Gene People UK, a UK-based registered charity, estimated that 1 in 25 children has a hereditary condition, equating to around 30,000 new diagnoses of hereditary conditions in babies and children annually in the UK, and over 2.4 million children and adults living with a genetic disorder. Consequently, the growing prevalence of cancer and genetic disorders is propelling the genotyping market forward.

The increasing demand for genetic testing is also expected to contribute to the growth of the genotyping market. Genetic testing, involving the analysis of an individual's DNA to identify variations or mutations, relies on genotyping to provide specific information about genetic differences. The utilization of genetic testing witnessed a notable 15% increase in November 2022 compared to the previous year, constituting approximately 10% of all lab tests and indicating a growing trend. This surge in demand for genetic testing further propels the growth of the genotyping market.

Innovations in product offerings are a prominent trend gaining traction in the genotyping market. Companies within the genotyping sector are embracing inventive solutions to maintain their competitive positions. A notable example is the collaboration between Neogen, a US-based food safety company, and Gencove Inc., a US-based provider of a sequencing platform for genome discovery, leading to the introduction of InfiniSEEK in May 2022. This groundbreaking and cost-effective solution revolutionizes whole genome sequencing and targeted SNP (single nucleotide polymorphism) analysis, particularly catering to cattle breeders. InfiniSEEK provides a platform for managing over 400 bovine genetic characteristics, identifying new variables affecting desirable phenotypes, and mitigating selection bias by sequencing larger populations or the entire population. This unique service empowers consumers with a data-rich, cost-effective approach to globally profile cattle, integrating genome-wide sequencing data, specific genetic traits, and parentage markers.

Major players in the genotyping market are directing their focus toward the development of cutting-edge solutions, exemplified by the emphasis on high-coverage whole genome sequencing. This advanced genetic sequencing technique involves a comprehensive analysis of an individual's entire genome with high coverage. A notable initiative in this direction is the collaboration between Gencove, a US-based software company, and NEOGEN Corporation, a US-based food safety company, leading to the launch of InfiniSEEK in May 2022. This groundbreaking and cost-efficient solution enables the simultaneous execution of low-pass whole genome sequencing and high-coverage genotyping in specific regions of interest.

In April 2022, LGC, a life sciences company based in the UK, acquired Rapid Genomics for an undisclosed sum. This acquisition is intended to strengthen LGC's position in the agrigenomics market by incorporating Rapid Genomics' Next-Generation Sequencing (NGS) technology and services. Rapid Genomics, a biotechnology firm located in the US, specializes in offering NGS kits and services for genotyping.

Major companies operating in the genotyping market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics

North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genotyping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genotyping market consists of revenues earned by entities by providing services such as custom genotyping services, genetic counselling, genotyping assay services, Sanger sequencing, fragment length analysis, and genotyping data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The genotyping market also includes sales of thermal cyclers, PCR (polymerase chain reaction) systems, fully integrated microarray instrument, which are used in providing genotyping services. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genotyping Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genotyping market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for genotyping ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genotyping market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Genotyping Market Characteristics

3. Genotyping Market Trends And Strategies

4. Genotyping Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Genotyping Growth Analysis And Strategic Analysis Framework

6. Genotyping Market Segmentation

7. Genotyping Market Regional And Country Analysis

8. Asia-Pacific Genotyping Market

9. China Genotyping Market

10. India Genotyping Market

11. Japan Genotyping Market

12. Australia Genotyping Market

13. Indonesia Genotyping Market

14. South Korea Genotyping Market

15. Western Europe Genotyping Market

16. UK Genotyping Market

17. Germany Genotyping Market

18. France Genotyping Market

19. Italy Genotyping Market

20. Spain Genotyping Market

21. Eastern Europe Genotyping Market

22. Russia Genotyping Market

23. North America Genotyping Market

24. USA Genotyping Market

25. Canada Genotyping Market

26. South America Genotyping Market

27. Brazil Genotyping Market

28. Middle East Genotyping Market

29. Africa Genotyping Market

30. Genotyping Market Competitive Landscape And Company Profiles

31. Genotyping Market Other Major And Innovative Companies

32. Global Genotyping Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genotyping Market

34. Recent Developments In The Genotyping Market

35. Genotyping Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기